4//SEC Filing
Wirostko Barbara 4
Accession 0001144204-19-005042
CIK 0001372514other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:36 PM ET
Size
5.7 KB
Accession
0001144204-19-005042
Insider Transaction Report
Form 4
Wirostko Barbara
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2019-02-01+50,000→ 50,000 totalExercise: $0.48Exp: 2029-02-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2020, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001669087
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:36 PM ET
- Size
- 5.7 KB